Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06835919 crossover study in non-alcoholic fatty liver disease
NL-OMON51756Phase 2Recruiting
- Sponsor
- Maastricht University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of PF-06835919, sponsored by Maastricht University. Started Oct 2022; status: recruiting.
02
Drugs
PF-06835919
Beyond the preview
Go deeper on NL-OMON51756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51756.